The company is actively advancing several clinical programs: INTEGRIS-PSC Phase 2a Trial: Recent interim results demonstrated bexotegrast’s potential in treating PSC, showing reductions in Enhanced Liver Fibrosis (ELF) score and PRO-C3 levels with statistical significance at the 160 mg dose. BEACON-IPF Phase 2b/3 Trial: This adaptive trial design aims to accelerate the development timeline by immediately transitioning from Phase 2b to Phase 3 upon enrollment completion. PLN-1474: A small molec...
Tesla Trading Up 14.8 % · Wall Street Analysts Forecast Growth · Hedge Funds Weigh In On Tesla · Tesla Company Profile · See Also
December 29, 2023 · Integris Group Completes MedMal Direct Insurance Company Transaction · GLASTONBURY, CT – January 5, 2024 – Integris Group, a leading member-owned medical professional liability insurance company, is pleased to announce the purchase of 100% of the stock of MedMal Direct Insurance Company (MDIC), and its agency, CorePRO Insurance, from Physicians Trust, Inc. (PTI). The transaction, having received PTI shareholder and regulatory approvals, closed December 31, 2023. ...
Sound Income Strategies LLC now owns 10,302 shares of the company's stock worth $52,000 after purchasing an additional 10,000 shares in the last quarter. Integris Wealth Management LLC...
13 analyst ratings ; buy : 100%, hold : 0%, sell : 0%
The Fly · Pliant Therapeutics assumed with an Outperform at Leerink · 2M ago · PLRX ; The Fly · Pliant Therapeutics price target raised to $38 from $36 at H.C. Wainwright · 3M ago · PLRX
In the managed service provider (MSP) industry, rapid growth through mergers and acquisitions often comes at the expense of service consistency and internal culture. Many MSP owners are familiar with the story of a private equity-backed company sweeping in, paying top dollar for the company, and gutting it at the expense of the company’s people and culture. Most of the companies ChannelE2E has profiled in our ongoing series on platform MSPs work to avoid fulfilling this trope. For Cranbury Tow...
This compares to the stock's 11.9% loss over the past four weeks. Share price surged as the company announced that its mid stage INTEGRIS-PSC study on lead pipeline candidate, bexotegrast...
to issue 48.75 million shares in common stock, after conditions... its stock exceeded $150 before the end of 2025. On Tuesday, T-Mobile’s stock closed at $156.83, triggering the clause. T...
Commercial real estate has historically outperformed the stock market, but few investors have... Now: Integris Secured Credit Fund IV The fund provides a fixed annual return of 12%, payable...